Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
NASDAQ: AGIO$36.34 Stock is Down 0.14 (0.38%)

UPCOMING EVENTS

Read more
Thursday, February 18, 2016 8:30 a.m. ET
Q4 2015 Agios Pharmaceuticals Inc Earnings Conference Call

CONTACTS

Investor Inquiries:
General inquiries: investors@agios.com

Institutional Investors and Financial Analysts:
Renee Leck
617-649-8299
renee.leck@agios.com

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085